VERTEX PHARMACEUTICALS INC / MA Capital Expenditures 2008-2026 | VRTX
What is capital expenditures?
Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.
What is VERTEX PHARMACEUTICALS INC / MA's current capital expenditures?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual capital expenditures for 2025 was $437.6M, a 46.99% increase from 2024. VERTEX PHARMACEUTICALS INC / MA capital expenditures for the quarter ending March 31, 2026 was $133.4M.
What was VERTEX PHARMACEUTICALS INC / MA's capital expenditures in 2024?
VERTEX PHARMACEUTICALS INC / MA annual capital expenditures for 2024 was $297.7M, a 48.55% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's capital expenditures in 2023?
VERTEX PHARMACEUTICALS INC / MA annual capital expenditures for 2023 was $200.4M, a 2.10% decline from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year capital expenditures CAGR?
VERTEX PHARMACEUTICALS INC / MA capital expenditures grew at a compound annual growth rate (CAGR) of 10.99% from FY2020 to FY2025, going from $259.8M to $437.6M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $437.6M | +47.0% | 10-K |
| FY2024 | $297.7M | +48.6% | 10-K |
| FY2023 | $200.4M | -2.1% | 10-K |
| FY2022 | $204.7M | -12.9% | 10-K |
| FY2021 | $235.0M | -9.5% | 10-K |
| FY2020 | $259.8M | +244.6% | 10-K |
| FY2019 | $75.4M | -21.0% | 10-K |
| FY2018 | $95.4M | -4.0% | 10-K |
| FY2017 | $99.4M | +75.8% | 10-K |
| FY2016 | $56.6M | +24.9% | 10-K |
| FY2015 | $45.3M | -11.5% | 10-K |
| FY2014 | $51.2M | -0.4% | 10-K |
| FY2013 | $51.4M | -27.8% | 10-K |
| FY2012 | $71.1M | +105.6% | 10-K |
| FY2011 | $34.6M | -9.1% | 10-K |
| FY2010 | $38.1M | +62.0% | 10-K |
| FY2009 | $23.5M | -27.0% | 10-K |
| FY2008 | $32.2M | - | 10-K |